Chemours has faced significant challenges, including weak demand, excess supply, and poor earnings. Read more to see why CC ...

Explore Chemours' Q1 2025 earnings insights, highlighting Opteon sales growth, strategic partnerships, and financial outlook amidst market challenges.

With demand for critical minerals picking up and new support from Washington, Chemours (CC) is back in the news. Early in ...

Chemours (NYSE:CC) tumbled 10% in extended trading Tuesday after the chemical maker reported a net loss for the first quarter ...

Chemours and Navin Fluorine Announce Agreement to Manufacture New Liquid Cooling Product as a Part of Chemours Expanded ...

The Chemours Company ("Chemours" or "the Company") (NYSE: CC), a global chemistry company with leading market positions in ...

Navin Fluorine International Limited has announced a strategic agreement with The Chemours Company to manufacture and ...

The results fell short of Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for earnings of 19 cents per share. The chemical company posted ...

The Chemours Company has been recognized by the U.S. Department of Energy’s Better Buildings, Better Plants Initiative with ...

During a meeting Friday, EPA leaders encouraged more than 1,500 within its Office of Research and Development to reapply for ...

Under the agreement, Navin Fluorine will establish manufacturing facility at Surat, Gujarat, at an estimated capex of $14MN, including $5MN of contribution by Chemours. The project is expected to be ...

Chemours and its PAC gave $16,500 to NC GOP lawmakers amid PFAS legislation debate, raising concerns from residents living near polluted water sources.